James Mullen
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
James C. Mullen ist ein Geschäftsmann, der an der Spitze von 11 verschiedenen Unternehmen gestanden hat und derzeit die Position des Non-Executive Chairman bei Percivia LLC, Chairman, President & Chief Executive Officer von Editas Medicine, Inc. und Chief Executive Officer für DPx Holdings BV innehat. Er ist außerdem im Vorstand von Thermo Fisher Scientific, Inc. und The Rivers School Corp. sowie Mitglied des Biomedical Sciences Careers Program, Inc. In der Vergangenheit hatte James C. Mullen die Position des Executive Chairman bei Vicarius Pharma AG, President, Chief Executive Officer & Director bei Biogen, Inc. Direktor bei Biogen Idec, Inc. (North Carolina) und Präsident bei Biogen Idec New Ventures, Inc. (beides sind Tochtergesellschaften von Biogen, Inc.), Chairman bei Torque Therapeutics, Inc, Chief Executive Officer & Non-Independent Director bei Patheon, Inc, Chief Executive Officer & Executive Director bei Patheon NV, Principal bei GlaxoSmithKline LLC und Chairman für Biotechnology Innovation Organization. Er erhielt einen MBA von der Villanova University und einen Bachelor-Abschluss vom Rensselaer Polytechnic Institute.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.02.2026 | 3.393 ( 0 % ) | 2 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Biomedical Sciences Careers Program, Inc. | Corporate Officer/Principal | - |
Percivia LLC
Percivia LLC Miscellaneous Commercial ServicesCommercial Services Provides research for developing vaccine and recombinant protein products | Vorsitzender | - |
The Rivers School Corp.
The Rivers School Corp. Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade Provides pharmaceutical services, fine chemicals and proprietary products and technologies | Vorstandsvorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Direktor/Vorstandsmitglied | 20.05.2026 |
| EDITAS MEDICINE, INC. | Vorstandsvorsitzender | 01.06.2022 |
| INSULET CORPORATION | Direktor/Vorstandsmitglied | 28.01.2019 |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Vorsitzender | 25.01.2019 |
| PATHEON N.V. | Vorstandsvorsitzender | 29.08.2017 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 19 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Patheon, Inc.
Patheon, Inc. Pharmaceuticals: MajorHealth Technology Provides drug development and manufacturing services | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Insulet Corp.
Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems | Health Technology |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Percivia LLC
Percivia LLC Miscellaneous Commercial ServicesCommercial Services Provides research for developing vaccine and recombinant protein products | Commercial Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Biomedical Sciences Careers Program, Inc. | |
The Rivers School Corp.
The Rivers School Corp. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade Provides pharmaceutical services, fine chemicals and proprietary products and technologies | Retail Trade |
Patheon NV
Patheon NV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services | Health Technology |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Health Technology |
Vicarius Pharma AG
Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides research and development services for pharmaceutical, biotech and medical companies | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen